Neuren Pharmaceuticals Ltd Sustainability Reports
Neuren Pharmaceuticals Limited is a biopharmaceutical company developing new drug therapies to treat serious neurodevelopmental disabilities and neurological conditions. Its pipeline includes treatments for disorders such as Rett syndrome, Fragile X syndrome, and Phelan-McDermid syndrome.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 984500E48D0FDEE7CE63
FIGI: BBG001SFQMB4
13 reports from 2006 to 2024
